http://rxforpr.com/2012/05/21/russo-partners-writes-front-page-article-for-lifelines/2012-05-21T15:00:35+00:00monthlyhttp://rxforpr.com/2012/05/11/spring-financing-round-up-alder-biopharmaceuticals-argos-therapeutics-and-sutro-biopharma-raise-venture-capital-funding/2012-05-11T12:57:39+00:00monthlyhttp://rxforpr.com/2012/05/07/endocyte-forms-partnership-with-merck-worth-up-to-1-billion/2012-05-07T15:42:36+00:00monthlyhttp://rxforpr.com/2012/04/17/russo-partners-attends-biocom-breakfast-meeting-featuring-a-panel-of-experts-discussing-personalized-medicine/2012-04-17T18:18:09+00:00monthlyhttp://rxforpr.com/2012/04/09/added-validation-for-antibody-drug-conjugates-adcs-as-roche-announces-positive-results-from-phase-3-study/2012-04-09T18:06:26+00:00monthlyhttp://rxforpr.com/2012/03/27/amid-growing-fears-of-antibiotic-resistance-cempras-therapeutics-offer-a-promising-solution/2012-03-27T18:58:57+00:00monthlyhttp://rxforpr.com/2012/03/19/merck-creates-the-california-institute-for-biomedical-research-calibr-located-in-san-diego/2012-03-19T17:39:31+00:00monthlyhttp://rxforpr.com/2012/03/12/aragon-pharmaceuticals-secures-42-million-in-series-c-financing-to-advance-pipeline-of-therapies-targeting-hormone-driven-cancers-announces-positive-phase-1-data-for-prostate-cancer-program/2012-03-12T18:51:25+00:00monthlyhttp://rxforpr.com/2012/03/02/molecularhealth-forms-collaboration-with-fda-to-develop-tools-for-predicting-drug-safety/2012-03-02T18:29:53+00:00monthlyhttp://rxforpr.com/2012/02/16/amdec-launches-upgrades-expands-the-f-i-r-s-t-registry/2012-02-16T18:52:49+00:00monthlyhttp://rxforpr.com/2012/02/06/back-to-basics-3-key-tips-for-developing-an-effective-pitch/2012-02-06T18:43:06+00:00monthlyhttp://rxforpr.com/2012/01/24/first-study-demonstrating-safety-of-embryonic-stem-cell-esc-derived-cells-in-humans-reported-by-advanced-cell-technology-results-published-in-the-lancet/2012-01-24T23:32:41+00:00monthlyhttp://rxforpr.com/2012/01/23/fda-accepts-resubmission-of-new-drug-application-for-arena-pharmaceuticals-obesity-drug-candidate-lorcaserin/2012-01-23T21:26:39+00:00monthlyhttp://rxforpr.com/2012/01/17/russo-partners-attends-the-30th-annual-jpmorgan-healthcare-conference/2012-01-17T20:32:54+00:00monthlyhttp://rxforpr.com/2012/01/09/the-fda-becomes-more-social/2012-01-12T16:51:38+00:00monthlyhttp://rxforpr.com/2011/12/23/happy-holidays-from-russo-partners-2/2011-12-23T19:57:33+00:00monthlyhttp://rxforpr.com/2011/12/21/russo-partners-west-coast-office-welcomes-attendees-of-the-53rd-annual-meeting-of-the-american-society-of-hematology-ash-to-san-diego/2011-12-21T15:51:02+00:00monthlyhttp://rxforpr.com/2011/12/14/russo-partners-kicks-off-jpmorgan-preparations/2011-12-14T15:13:53+00:00monthlyhttp://rxforpr.com/2011/12/05/1214/2011-12-05T20:28:07+00:00monthlyhttp://rxforpr.com/2011/11/28/advanced-cell-technology-leader-in-the-human-embryonic-stem-cell-space/2011-11-28T20:22:01+00:00monthlyhttp://rxforpr.com/2011/11/21/inviting-the-media-to-life-sciences-summit-2011/2011-11-21T18:23:27+00:00monthlyhttp://rxforpr.com/2011/11/15/introducing-orbusneich%e2%80%99s-combo-tm-dual-therapy-stent/2011-11-15T17:39:39+00:00monthlyhttp://rxforpr.com/2011/11/07/media-relations-the-importance-of-dialogue/2011-11-07T19:22:19+00:00monthlyhttp://rxforpr.com/2011/11/02/ringing-the-nasdaq-closing-bell/2011-11-02T22:22:30+00:00monthlyhttp://rxforpr.com/2011/10/31/bio-investor-forum-supporting-our-clients%e2%80%99-participation-as-panelists-presenters/2011-10-31T17:26:16+00:00monthlyhttp://rxforpr.com/2011/10/24/congratulations-to-cellular-dynamics-international-cdi-gold-winner-of-the-wall-street-journal%e2%80%99s-2011-technology-innovation-awards/2011-10-24T16:27:54+00:00monthlyhttp://rxforpr.com/2011/10/15/developing-the-company-%e2%80%9cstory%e2%80%9d/2011-10-17T16:25:58+00:00monthlyhttp://rxforpr.com/2011/10/07/obesity-the-week-in-review/2011-10-07T23:14:21+00:00monthlyhttp://rxforpr.com/2011/09/30/working-like-a-company-executive/2011-09-30T18:26:38+00:00monthlyhttp://rxforpr.com/2011/09/23/raising-awareness-of-at-the-market-offerings/2011-09-23T21:32:51+00:00monthlyhttp://rxforpr.com/2011/09/22/advanced-cell-technology-receives-approval-for-first-european-embryonic-stem-cell-trial/2011-09-22T22:06:40+00:00monthlyhttp://rxforpr.com/2011/09/16/a-warm-welcome-to-cindy-mcgee/2011-09-16T21:41:18+00:00monthlyhttp://rxforpr.com/2011/09/09/pitching-the-real-world-solution-to-the-fictional-threat-of-%e2%80%98contagion%e2%80%99/2011-09-09T17:23:06+00:00monthlyhttp://rxforpr.com/2011/09/01/the-three-do%e2%80%99s-of-working-with-the-media/2011-09-01T22:34:03+00:00monthlyhttp://rxforpr.com/2011/08/26/sometimes-the-cover-isn%e2%80%99t-all-it%e2%80%99s-cracked-up-to-be/2011-08-26T17:16:29+00:00monthlyhttp://rxforpr.com/2011/08/19/is-social-media-a-friend-or-foe-for-biotechs-it-depends/2011-08-25T17:13:44+00:00monthlyhttp://rxforpr.com/2011/08/11/a-congratulations-to-amira-pharmaceuticals/2011-08-11T21:15:39+00:00monthlyhttp://rxforpr.com/2011/08/04/more-than-a-memory-capturing-influential-thought-leaders-on-film/2011-08-04T17:04:49+00:00monthlyhttp://rxforpr.com/2011/07/14/social-communications-healthcare-2011-case-studies-and-roundtables/2011-07-14T16:32:31+00:00monthlyhttp://rxforpr.com/2011/06/20/twitter-and-biotech-why-it-matters-now/2011-07-05T20:20:10+00:00monthlyhttp://rxforpr.com/2011/06/10/the-consequences-of-issuing-an-inaccurate-press-release/2011-06-10T15:39:19+00:00monthlyhttp://rxforpr.com/2011/05/25/update-on-fda-and-guidance-delays-for-pharmas-use-of-social-media/2011-05-25T17:19:55+00:00monthlyhttp://rxforpr.com/2011/04/14/biopharmaceuticals-social-media-and-the-fda-%e2%80%93-what-can-we-say/2011-07-10T01:15:06+00:00monthlyhttp://rxforpr.com/2011/04/07/a-cost-effective-idea-for-start-up-biotech-companies/2011-04-07T20:36:15+00:00monthlyhttp://rxforpr.com/2011/04/01/have-some-industry-specific-terms-become-meaningless/2011-04-01T15:34:37+00:00monthlyhttp://rxforpr.com/2011/03/29/softening-the-downside-of-uncertain-news-part-4/2011-03-31T19:43:53+00:00monthlyhttp://rxforpr.com/2011/03/25/softening-the-downside-of-uncertain-news-part-3/2011-03-25T17:36:33+00:00monthlyhttp://rxforpr.com/2011/03/21/softening-the-downside-of-uncertain-news-part-2/2011-03-21T21:42:21+00:00monthlyhttp://rxforpr.com/2011/03/18/softening-the-downside-of-uncertain-news/2011-03-18T22:09:32+00:00monthlyhttp://rxforpr.com/2011/02/15/smartphone-apps-target-physicians-patients-and-drug-developers/2011-02-15T15:51:59+00:00monthlyhttp://rxforpr.com/2011/02/10/utilizing-youtube-to-promote-your-company-and-educate-the-public/2011-02-10T23:02:29+00:00monthlyhttp://rxforpr.com/2011/02/07/cell-press-announces-new-iphone-app-cell-alerts/2011-02-07T22:58:40+00:00monthlyhttp://rxforpr.com/2011/01/28/the-beat-of-ips-cells/2011-01-28T21:47:17+00:00monthlyhttp://rxforpr.com/2011/01/13/big-pharma-and-academic-research-go-steady-at-jpmorgan/2011-01-13T22:11:06+00:00monthlyhttp://rxforpr.com/2011/01/07/a-bacterial-colony-grows-in-brooklyn/2011-01-07T22:36:45+00:00monthlyhttp://rxforpr.com/2010/12/22/happy-holidays-from-russo-partners/2010-12-22T18:11:58+00:00monthlyhttp://rxforpr.com/2010/12/13/a-tour-of-popular-science-on-the-ipad/2010-12-13T23:02:24+00:00monthlyhttp://rxforpr.com/2010/12/13/ipads-can-sell-medical-devices-too/2010-12-13T22:52:07+00:00monthlyhttp://rxforpr.com/2010/12/06/nejm-where-the-health-industry-stands-on-social-media/2010-12-06T23:41:03+00:00monthlyhttp://rxforpr.com/2010/11/24/from-dna-to-protein/2010-11-24T00:31:53+00:00monthlyhttp://rxforpr.com/2010/11/24/taking-science-to-the-people/2010-11-24T00:08:56+00:00monthlyhttp://rxforpr.com/2010/11/18/the-value-of-a-sound-bite/2010-11-18T20:54:40+00:00monthlyhttp://rxforpr.com/2010/11/12/video-and-public-relations/2010-11-12T22:59:58+00:00monthlyhttp://rxforpr.com/2010/11/11/pharmaceutical-executive-magazine-roundtable-building-on-the-commercial-and-policy-base-for-effective-collaboration-in-biotech/2010-11-11T00:40:34+00:00monthlyhttp://rxforpr.com/2010/11/05/top-10-medical-innovations-for-2011/2010-11-05T22:35:54+00:00monthlyhttp://rxforpr.com/2010/11/05/diagnosing-and-treating-the-high-cost-of-healthcare/2010-11-05T21:56:09+00:00monthlyhttp://rxforpr.com/2010/10/29/antibodies-and-alzheimers/2010-10-29T21:29:02+00:00monthlyhttp://rxforpr.com/2010/10/28/superbugs-are-still-a-problem/2010-10-28T20:38:11+00:00monthlyhttp://rxforpr.com/2010/10/22/challenging-diseases-hcv/2010-10-22T20:21:05+00:00monthlyhttp://rxforpr.com/2010/10/22/the-cost-of-personalized-immunotherapy/2010-10-22T18:42:05+00:00monthlyhttp://rxforpr.com/2010/10/15/genetic-diseases-no-longer-insignificant/2010-10-15T22:03:39+00:00monthlyhttp://rxforpr.com/2010/10/15/advertorial-vs-editorial-the-blog-issue/2010-10-15T21:54:11+00:00monthlyhttp://rxforpr.com/2010/10/05/a-supreme-court-justice-and-his-personal-stock-portfolio/2010-10-05T16:05:07+00:00monthlyhttp://rxforpr.com/2010/10/05/linking-in/2010-10-05T15:29:18+00:00monthlyhttp://rxforpr.com/2010/08/20/getting-facts-right/2010-08-20T18:29:13+00:00monthlyhttp://rxforpr.com/2010/07/30/a-story-of-ideas/2010-07-30T19:42:40+00:00monthlyhttp://rxforpr.com/2010/07/16/simple-stories-better-outcomes/2010-07-19T19:20:03+00:00monthlyhttp://rxforpr.com/2010/07/07/the-science-of-healthy-communication/2010-07-07T22:50:58+00:00monthlyhttp://rxforpr.com/2010/06/25/learn-to-really-listen/2010-06-25T19:04:51+00:00monthlyhttp://rxforpr.com/2010/06/17/under-embargo-at-ada/2010-06-17T19:43:01+00:00monthlyhttp://rxforpr.com/2010/06/10/fda-online-guidance-tbd-in-2010/2010-06-10T20:40:50+00:00monthlyhttp://rxforpr.com/2010/06/04/a-new-genesis/2010-06-04T18:08:13+00:00monthlyhttp://rxforpr.com/2010/05/19/ascos-big-reveal/2010-05-19T17:56:30+00:00monthlyhttp://rxforpr.com/2010/05/10/for-your-consideration-health-blogs/2010-05-10T20:57:48+00:00monthlyhttp://rxforpr.com/2010/05/07/the-health-blog/2010-05-07T22:10:23+00:00monthlyhttp://rxforpr.com/2010/04/30/the-e-newsletter/2010-04-30T22:14:43+00:00monthlyhttp://rxforpr.com/2010/04/28/informed-consent/2010-04-28T22:21:54+00:00monthlyhttp://rxforpr.com/2010/04/16/health-news-literacy/2010-04-16T23:36:41+00:00monthlyhttp://rxforpr.com/2010/04/09/five-sentences-10-slides/2010-04-09T22:52:30+00:00monthlyhttp://rxforpr.com/2010/04/06/healthcare-video-tips/2010-04-06T19:05:53+00:00monthlyhttp://rxforpr.com/2010/03/31/reading-2-0/2010-03-31T21:44:41+00:00monthlyhttp://rxforpr.com/2010/03/26/interactive-news-what-a-visual-can-do/2010-03-26T19:36:16+00:00monthlyhttp://rxforpr.com/2010/03/26/interactive-news/2010-03-26T19:33:28+00:00monthlyhttp://rxforpr.com/2010/03/24/washington-pr-blitz-healthcare-reform/2010-03-24T22:47:42+00:00monthlyhttp://rxforpr.com/2010/03/22/a-few-simple-reminders/2010-03-22T22:11:51+00:00monthlyhttp://rxforpr.com/2010/03/19/a-conversation-about-healthcare/2010-03-19T23:06:18+00:00monthlyhttp://rxforpr.com/2010/03/09/let-twitter-do-the-work/2010-03-09T22:48:32+00:00monthlyhttp://rxforpr.com/2010/03/04/we-blog-should-you/2010-03-04T23:26:13+00:00monthlyhttp://rxforpr.com/2010/02/26/how-to-make-a-first-impression-headline-dos-and-donts/2010-02-26T21:56:48+00:00monthlyhttp://rxforpr.com/2010/02/22/rule-7-do-not-overstate/2010-02-22T23:59:17+00:00monthlyhttp://rxforpr.com/2010/02/19/should-global-warming-be-called-global-weirding/2010-02-19T21:42:59+00:00monthlyhttp://rxforpr.com/2010/02/11/symphony-of-science/2011-04-19T03:57:42+00:00monthlyhttp://rxforpr.com/2010/02/12/pr-advice-what-to-do-in-a-recall/2010-02-12T23:31:17+00:00monthlyhttp://rxforpr.com/2010/02/10/the-science-literacy-investment/2010-02-10T19:43:17+00:00monthlyhttp://rxforpr.com/2010/02/03/newspaper-articles-are-to-long/2010-02-10T19:32:05+00:00monthlyhttp://rxforpr.com/2010/02/05/rx-for-clarity/2010-02-05T21:34:59+00:00monthlyhttp://rxforpr.com/2010/02/01/an-introduction-to-extraordinary-measures/2010-02-01T20:08:27+00:00monthlyhttp://rxforpr.com/2010/01/29/mapping-science/2010-01-29T19:11:42+00:00monthlyhttp://rxforpr.com/2010/01/27/facebook-is-still-not-face-to-face/2010-01-27T17:54:23+00:00monthlyhttp://rxforpr.com/2010/01/22/health-cares-new-information-technology/2010-01-22T19:26:21+00:00monthlyhttp://rxforpr.com/2010/01/20/crisis-communication/2010-01-20T17:47:05+00:00monthlyhttp://rxforpr.com/2010/01/15/multimedia-content-in-news-releases/2010-01-15T15:50:08+00:00monthlyhttp://rxforpr.com/2010/01/13/taking-the-internet-to-heart/2010-01-13T15:02:47+00:00monthlyhttp://rxforpr.com/2009/12/14/effective-use-of-news-releases/2009-12-14T15:24:56+00:00monthlyhttp://rxforpr.com/2009/12/11/high-standards-for-communicating-biomedical-research-results/2009-12-11T23:02:24+00:00monthlyhttp://rxforpr.com/2009/12/11/less-is-more/2009-12-11T22:56:06+00:00monthlyhttp://rxforpr.com/2009/11/20/fighting-against-the-tide-of-dogma/2009-11-20T23:19:24+00:00monthlyhttp://rxforpr.com/2009/11/19/quick-and-dirty-pr/2009-11-19T00:49:19+00:00monthlyhttp://rxforpr.com/2009/11/07/media-silence-is-not-the-answer-when-misquoted-by-a-journalist/2009-11-07T00:27:27+00:00monthlyhttp://rxforpr.com/2009/10/14/opportunities-and-responsibilities-of-freedom-of-speech/2009-10-14T22:22:42+00:00monthlyhttp://rxforpr.com/2009/10/07/managing-the-%e2%80%9cpost-journalistic-world%e2%80%9d/2009-10-07T23:14:54+00:00monthlyhttp://rxforpr.com/2009/10/02/funding-drug-research-may-be-shrinking/2009-10-02T13:20:53+00:00monthlyhttp://rxforpr.com/2009/09/23/being-part-of-the-conversation/2009-09-23T15:32:03+00:00monthlyhttp://rxforpr.com/2009/09/12/burrill-company%e2%80%99s-latest-update-on-the-biotech-industry-maintains-a-positive-outlook-despite-a-cooling-off-in-august/2009-09-12T15:46:48+00:00monthlyhttp://rxforpr.com/2009/09/03/increasing-interest-in-oncology-treatments-for-profit/2009-09-03T23:05:11+00:00monthlyhttp://rxforpr.com/2009/08/28/investors-are-willing-to-pay-a-premium-for-good-ir-practices/2009-08-28T21:48:40+00:00monthlyhttp://rxforpr.com/2009/08/26/thomson-reutersbio-perception-study-predicts-biotech-sector-will-outperform-in-relative-and-absolute-terms-in-2009/2009-08-26T13:47:26+00:00monthlyhttp://rxforpr.com/2009/08/17/the-fans-know-best-mondays-wsj-article/2009-08-17T17:58:31+00:00monthlyhttp://rxforpr.com/2009/08/13/tavistock-group%e2%80%99s-shehan-dissanayake-sees-good-times-ahead-in-the-life-sciences-market/2009-08-13T13:24:57+00:00monthlyhttp://rxforpr.com/2009/08/03/timely-tweets-can-help-maintain-a-good-corporate-image/2009-08-03T21:25:19+00:00monthlyhttp://rxforpr.com/2009/07/27/in-the-digital-age-good-business-means-a-good-web-site/2009-07-28T14:14:46+00:00monthlyhttp://rxforpr.com/2009/07/24/organizing-outreach-to-medical-device-markets/2009-07-24T18:43:12+00:00monthlyhttp://rxforpr.com/2009/07/20/staying-smart-with-social-media/2009-07-20T20:31:11+00:00monthlyhttp://rxforpr.com/2009/07/17/new-perspectives-on-new-media/2009-07-17T18:32:50+00:00monthlyhttp://rxforpr.com/2009/07/14/pitch-perfect-tips-for-impressing-investors/2009-07-16T19:26:27+00:00monthlyhttp://rxforpr.com/2009/07/09/tough-times-for-biotech-and-how-pr-can-help-tony-russo-talks-to-pr-week/2009-07-09T19:52:30+00:00monthlyhttp://rxforpr.com/2009/07/06/good-news-for-amira/2009-07-06T19:16:09+00:00monthlyhttp://rxforpr.com/2009/06/18/notable-mention-for-ardea-and-russo-partners/2009-06-18T14:02:56+00:00monthlyhttp://rxforpr.com/2009/05/29/bmo-capital-markets-jim-love-shares-thoughts-on-current-healthcare-financing-market/2009-05-29T21:43:56+00:00monthlyhttp://rxforpr.com/2009/05/15/connectivity-story-takes-flight-at-heart-rhythm-2009/2009-05-15T15:42:51+00:00monthlyhttp://rxforpr.com/2009/05/12/connectivity-at-heart-rhythm-2009-russo-partners-topic-of-the-week/2009-05-12T19:00:16+00:00monthlyhttp://rxforpr.com/2009/05/06/putting-tech-tools-to-work-to-drum-up-support/2009-05-06T21:51:35+00:00monthlyhttp://rxforpr.com/2009/04/30/good-healthcare-newsmaker-in-action-cdc-official-draws-on-tv-skills-for-flu-updates/2009-04-30T18:37:32+00:00monthlyhttp://rxforpr.com/2009/04/28/renewed-optimism-with-capital-markets-says-deutsche-bank-healthcare-vp/2009-04-28T22:43:26+00:00monthlyhttp://rxforpr.com/2009/04/27/corporate-blogs-and-tweets-keep-sec-in-mind/2009-04-27T19:29:18+00:00monthlyhttp://rxforpr.com/2009/04/19/participating-in-the-twitter-revolution/2009-04-27T14:48:30+00:00monthlyhttp://rxforpr.com/2009/04/19/evaluating-your-performance-as-a-newsmaker/2009-04-19T01:53:48+00:00monthlyhttp://rxforpr.com/2009/04/11/your-science-or-technology-is-on-the-cutting-edge-are-your-people/2009-04-11T03:56:29+00:00monthlyhttp://rxforpr.com/2009/04/06/march-wrap-up-clinical-data-presentations-take-center-stage/2009-04-06T12:47:07+00:00monthlyhttp://rxforpr.com/2009/03/31/media-relations-practices-at-medical-conferences-common-sense-with-journalists-prevails/2009-04-10T07:48:36+00:00monthlyhttp://rxforpr.com/2009/03/18/extra-extra-online-media-outlets-often-help-us-to-acheive-better-pr-outcomes/2009-03-24T18:58:01+00:00monthlyhttp://rxforpr.com/2009/03/24/unveiling-a-biopharma-company-requires-more-than-a-news-release/2009-03-24T16:53:15+00:00monthlyhttp://rxforpr.com/2009/03/19/a-view-on-financing-from-the-thomas-weisel-partners-healthcare-investment-bankers/2009-03-19T18:10:44+00:00monthlyhttp://rxforpr.com/2009/03/13/healthcare-investment-banker-john-chambers-shares-financing-tips-in-light-of-todays-market-conditions/2009-03-13T21:29:47+00:00monthlyhttp://rxforpr.com/2009/03/11/russo-partners-and-biocom-bring-bloomberg-reporter-to-san-diego/2009-03-11T19:12:53+00:00monthlyhttp://rxforpr.com/2009/03/11/journalists-have-rights-too/2009-03-11T18:32:53+00:00monthlyhttp://rxforpr.com/2009/03/09/know-your-rights-as-a-healthcare-newsmaker/2009-03-09T01:21:34+00:00monthlyhttp://rxforpr.com/2009/03/05/translating-the-promise-of-microrna-therapeutics-into-pr-success/2009-03-05T00:48:20+00:00monthlyhttp://rxforpr.com/2009/02/27/february-in-review-data-deals-and-many-developments/2009-02-27T23:05:33+00:00monthlyhttp://rxforpr.com/2009/02/25/russo-partners-uses-twitter-for-distribution-of-breaking-healthcare-news/2009-02-25T16:14:18+00:00monthlyhttp://rxforpr.com/2009/02/23/formalize-and-focus-pr-efforts-in-economic-downturn/2009-02-23T22:21:40+00:00monthlyhttp://rxforpr.com/2009/02/17/gerons-tom-okarma-discusses-innovation-in-healthcare-on-nightly-business-report/2009-02-17T01:32:07+00:00monthlyhttp://rxforpr.com/2009/02/13/e-mail-is-top-tool-in-web-20-communications-kit/2009-02-13T18:52:51+00:00monthlyhttp://rxforpr.com/2009/02/12/oppenheimer-investment-bankers-share-tips-for-healthcare-companies-in-search-of-funds/2009-02-12T22:08:07+00:00monthlyhttp://rxforpr.com/2009/02/06/preparation-is-critical-before-you-meet-the-press/2009-02-06T23:11:03+00:00monthlyhttp://rxforpr.com/2009/02/05/in-new-york-city-meet-science-and-healthcare-journalists-to-forge-relationships/2009-02-05T20:57:55+00:00monthlyhttp://rxforpr.com/2009/02/02/january-wrap-up-biotech-medtech-companies-off-to-fast-start/2009-02-02T02:19:28+00:00monthlyhttp://rxforpr.com/2009/01/29/life-science-vc-shares-3-things-to-think-about/2009-01-29T16:03:44+00:00monthlyhttp://rxforpr.com/2009/01/28/video-carries-stem-cell-story-worldwide/2009-01-28T20:55:12+00:00monthlyhttp://rxforpr.com/2009/01/20/newswires-still-important-in-web-20-media-world/2009-01-20T23:55:04+00:00monthlyhttp://rxforpr.com/2009/01/20/russo-partners-blue-state-digital-form-alliance-to-help-healthcare-companies-build-mobilize-online-communities/2009-01-20T02:20:18+00:00monthlyhttp://rxforpr.com/2009/01/20/gotta-have-vs-nice-to-have-words-from-a-leading-medtech-vc/2009-01-20T02:15:07+00:00monthlyhttp://rxforpr.com/about/2008-12-22T20:59:11+00:00weekly0.6http://rxforpr.com/daily1.02012-05-21T15:00:35+00:00